Back to Search Start Over

The dual role of C/EBPδ in cancer.

Authors :
Hartl L
Duitman J
Bijlsma MF
Spek CA
Source :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 May; Vol. 185, pp. 103983. Date of Electronic Publication: 2023 Apr 05.
Publication Year :
2023

Abstract

CCAAT/Enhancer-Binding Protein delta (C/EBPδ) is a transcription factor involved in differentiation and inflammation. While sparsely expressed in adult tissues, aberrant expression of C/EBPδ has been associated with different cancers. Initially, re-expression of C/EBPδ in cell cultures limited tumor cell proliferation, assigning it a tumor suppressor role. However, opposing observations were made in pre-clinical models and patients, suggesting that C/EBPδ not only mediates cell proliferation but dictates a broader spectrum of tumorigenesis-related effects. It is now widely accepted that C/EBPδ contributes to an inflammatory, tumor-promoting microenvironment, aids hypoxia adaption and contributes to the recruitment of blood vessels for improved nutrient supply to tumor cells and facilitated extravasation. This review summarizes the work published on this transcription factor in the field of cancer over the past decade. It points out areas in which a consensus on C/EBPδ's role appears to emerge and seek to explain seemingly contradictory results.<br />Competing Interests: Declaration of competing interest M.F.B. has received research funding from Celgene and Lead Pharma, and has acted as a consultant for Servier. None were involved in the design of this study or drafting of the manuscript. All other authors declare no conflict of interest.<br /> (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1879-0461
Volume :
185
Database :
MEDLINE
Journal :
Critical reviews in oncology/hematology
Publication Type :
Academic Journal
Accession number :
37024021
Full Text :
https://doi.org/10.1016/j.critrevonc.2023.103983